Pharmaceutical companies often struggle to actively involve patients in the design phase of clinical trials but doing so can have huge benefits for the sustainability and success of researc
UK healthcare authorities have approved a free messaging app for use in hospitals, in a move designed to stop staff sharing sensitive clinical information using consumer services such as Wh
The term “gate-keeper” implies only signatories are concerned with compliance with the ABPI Code of Practice, so we prefer the term “goalkeeper”; if the rest of the team are doing a poor jo
Novartis has struck another deal to build its position in radiopharmaceuticals, agreeing to pay $1 billion upfront for radioligand therapy (RLT) developer Mariana Oncology
It’s 2024, and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another.